Skip to main content

Research Repository

Advanced Search

Patient‐reported outcomes in studies of diabetes technology: What matters

Liarakos, Alexandros L.; Crabtree, Thomas S.J.; Wilmot, Emma G.

Patient‐reported outcomes in studies of diabetes technology: What matters Thumbnail


Authors

Alexandros L. Liarakos

Thomas S.J. Crabtree

Dr EMMA WILMOT Emma.Wilmot@nottingham.ac.uk
Clinical Associate Professor in Diabetes and Endocrinology



Abstract

In recent years, diabetes technologies have revolutionized the care of people with type1 diabetes (T1D). Emerging evidence suggests that people with type 2 diabetes (T2D) canexperience similar benefits from these advances in technology. While glycaemic outcomesare often a primary focus, the lived experience of the person with diabetes is equallyimportant. In this review, we describe the impact of diabetes technologies on patient-reported outcome measures (PROMs). We highlight that most of the published studiesinvestigated PROMs as secondary outcomes. Continuous glucose monitoring systems mayhave an important role in improving PROMs in individuals with T1D, which may be drivenby the prevention or proactive management of hypoglycaemia. In people with T2D, con-tinuous glucose monitoring may also have an important role in improving PROMs, particu-larly in those treated with insulin therapy. The impact of insulin pumps on PROMs seemspositive in T1D, while there is limited evidence in T2D. Studies of hybrid closed-loop ther-apies suggest increased treatment satisfaction, improved quality of life and decreaseddiabetes-related distress in T1D, but it is unclear whether these benefits are because of a‘class-effect’ or individual systems. We conclude that PROMs deserve a more central rolein trials and clinical practice, and we discuss directions for future research

Citation

Liarakos, A. L., Crabtree, T. S., & Wilmot, E. G. (2024). Patient‐reported outcomes in studies of diabetes technology: What matters. Diabetes, Obesity and Metabolism, 26(S7), 59-73. https://doi.org/10.1111/dom.15858

Journal Article Type Article
Acceptance Date Jul 20, 2024
Online Publication Date Dec 15, 2024
Publication Date 2024-12
Deposit Date Dec 31, 2024
Publicly Available Date Jan 7, 2025
Journal Diabetes, Obesity and Metabolism
Print ISSN 1462-8902
Electronic ISSN 1463-1326
Publisher Wiley
Peer Reviewed Peer Reviewed
Volume 26
Issue S7
Pages 59-73
DOI https://doi.org/10.1111/dom.15858
Keywords continuous glucose monitoring, continuous subcutaneous insulin infusion, insulin pump therapy,patient reported outcomes, type 1 diabetes, type 2 diabetes
Public URL https://nottingham-repository.worktribe.com/output/39176223
Publisher URL https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.15858

Files

Diabetes Obesity Metabolism - 2024 (1.1 Mb)
PDF

Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/

Copyright Statement
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.





You might also like



Downloadable Citations